Invesco Biotechnology & Genome ETF
PBE
PBE
60 hedge funds and large institutions have $92.6M invested in Invesco Biotechnology & Genome ETF in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+9
Holders Change %
+17.65%
% of All Funds
1.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
21
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$26.7M |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$11.1M |
| 3 |
U
3
UBS
Zurich,
Switzerland
|
$12.6M |
| 4 |
4
Wells Fargo
San Francisco,
California
|
$9.43M |
| 5 |
AIG
5
American International Group
New York
|
$762K |
